These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 8942221)
1. Cefuroxime compared to amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia. Oh HM; Ng AW; Lee SK Singapore Med J; 1996 Jun; 37(3):255-7. PubMed ID: 8942221 [TBL] [Abstract][Full Text] [Related]
2. Cefuroxime compared to amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia. Lim TK Singapore Med J; 1997 Mar; 38(3):139. PubMed ID: 9269388 [No Abstract] [Full Text] [Related]
3. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years. Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583 [TBL] [Abstract][Full Text] [Related]
4. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children. Kogan R; Martínez MA; Rubilar L; Payá E; Quevedo I; Puppo H; Girardi G; Castro-Rodriguez JA Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069 [TBL] [Abstract][Full Text] [Related]
5. [Prospective and comparative study between cefuroxime, ceftriaxone and amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia]. Sánchez ME; Gómez J; Gómez Vargas J; Baños V; Ruiz Gómez J; Muñoz L; Simarro E; Soto MC; Canteras M; Valdés M Rev Esp Quimioter; 1998 Jun; 11(2):132-8. PubMed ID: 9795298 [TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of amoxicillin, cefuroxime and clarithromycin in the treatment of community -acquired pneumonia in children. Aurangzeb B; Hameed A J Coll Physicians Surg Pak; 2003 Dec; 13(12):704-7. PubMed ID: 15569557 [TBL] [Abstract][Full Text] [Related]
7. Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia. Higuera F; Hidalgo H; Feris J; Giguere G; Collins JJ J Antimicrob Chemother; 1996 Mar; 37(3):555-64. PubMed ID: 9182112 [TBL] [Abstract][Full Text] [Related]
8. Is azithromycin monotherapy as efficacious as cefuroxime plus erythromycin for the treatment of community-acquired pneumonia in hospitalized patients? See S J Fam Pract; 2000 Oct; 49(10):883-4. PubMed ID: 11052155 [No Abstract] [Full Text] [Related]
9. Amoxycillin/clavulanic acid ('Augmentin') compared with a combination of aminopenicillin, aminoglycoside and metronidazole in the treatment of pelvic inflammatory disease. Cirau-Vigneron N; Barrier J; Becue J; Chartier M; Giraud JR; Landes P; Leng J; Raudrant D; Reme JM Pharmatherapeutica; 1989; 5(5):312-9. PubMed ID: 2664816 [TBL] [Abstract][Full Text] [Related]
10. [Clarithromycin versus amoxicillin-clavulanic acid in the treatment of acute maxillary sinusitis in adults]. Géhanno P; Barry B; Chauvin JP; Hazebroucq J Pathol Biol (Paris); 1996 Apr; 44(4):293-7. PubMed ID: 8763594 [TBL] [Abstract][Full Text] [Related]
11. A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults. Ortiz-Ruiz G; Caballero-Lopez J; Friedland IR; Woods GL; Carides A; Clin Infect Dis; 2002 Apr; 34(8):1076-83. PubMed ID: 11914996 [TBL] [Abstract][Full Text] [Related]
12. Augmentin (intravenous then oral) compared with cefuroxime followed by cephalexin for chest infections in hospitalised patients. O'Donovan C; Rudd R; O'Neill S; Fitzgerald MX; McNicholas W; Flavell-Matts SG; Howell F; McKenzie A; Whittaker J Br J Clin Pract; 1987 Dec; 41(12):1044-52. PubMed ID: 3332842 [No Abstract] [Full Text] [Related]
13. [Efficacy and safety of pristinamycin vs amoxicillin in community acquired pneumonia in adults]. Trémolières F; Mayaud C; Mouton Y; Weber P; Dellatolas F; Caulin E Pathol Biol (Paris); 2005; 53(8-9):503-10. PubMed ID: 16181747 [TBL] [Abstract][Full Text] [Related]
14. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials. Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462 [TBL] [Abstract][Full Text] [Related]
15. Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study. File TM; Mandell LA; Tillotson G; Kostov K; Georgiev O J Antimicrob Chemother; 2007 Jul; 60(1):112-20. PubMed ID: 17537866 [TBL] [Abstract][Full Text] [Related]
16. [Antibiotic prophylaxis for high risk patients undergoing cholecystectomy]. Zsirka KA; Pulay I; Arr M; Williams C; Flautner L Magy Seb; 2000 Jun; 53(3):104-8. PubMed ID: 11299497 [TBL] [Abstract][Full Text] [Related]
17. Cefuroxime and cefuroxime axetil versus amoxicillin plus clavulanic acid in the treatment of lower respiratory tract infections. Brambilla C; Kastanakis S; Knight S; Cunningham K Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):118-24. PubMed ID: 1396725 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of two therapeutic antibiotic regimens in the treatment of serious post-operative infections. Askew C; Lomax J; Lawson W; Kingston RD Br J Clin Pract; 1989 Dec; 43(12):438-42. PubMed ID: 2692686 [TBL] [Abstract][Full Text] [Related]
19. Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy. Welte T; Petermann W; Schürmann D; Bauer TT; Reimnitz P; Clin Infect Dis; 2005 Dec; 41(12):1697-705. PubMed ID: 16288390 [TBL] [Abstract][Full Text] [Related]
20. Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy. Anzueto A; Niederman MS; Pearle J; Restrepo MI; Heyder A; Choudhri SH; Clin Infect Dis; 2006 Jan; 42(1):73-81. PubMed ID: 16323095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]